ALXO
Alx Oncology Holdings
1.30$
+5.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
Alx Oncology Holdings (ALXO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.9 | -4.3 | -3.2 | -2.9 | -9.0 | -6.2 | -9.5 | -14 | -5.1 | -21 | -25 | -17 | -21 | -17 | -31 | -21 | -28 | -32 | -31 | -40 | -38 | -27 | -25 | -32 | -25 | -23 | -17 | -19 | -19 | -16 | -71 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.5 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 2.9 | 0.7 | 1.7 | 1.8 | 2.2 | 4.2 | 5.7 | 5.5 | 5.8 | 6.2 | 6.3 | 6.4 | 6.2 | 7.0 | 6.7 | 7.0 | 7.3 | 7.0 | 5.9 | 5.2 | 2.1 | 2.5 | 2.7 | 2.5 | 2.7 | 10 | |
| 0.1 | 0.1 | 0.1 | – | 0.3 | 3.2 | 0.8 | 2.4 | 1.9 | 2.4 | 4.2 | 11 | 5.5 | 6.0 | 6.2 | 6.3 | 6.4 | 4.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.2 | -0.3 | -0.3 | 4.7 | -4.0 | 1.8 | -0.3 | 2.7 | 7.2 | -6.7 | -4.7 | 0.3 | -2.1 | 9.8 | -1.8 | 4.0 | -3.4 | -2.7 | 14 | 0.3 | -8.6 | 6.2 | -1.3 | -8.8 | 0.6 | -3.2 | 2.1 | 0.7 | -3.6 | 0.5 | -0.3 | |
| 0.1 | 0.3 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 4.5 | 0.6 | 0.3 | 0.2 | 0.4 | 0.7 | 1.7 | 1.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.2 | |
| -0.1 | -0.3 | 0.0 | 0.1 | 0.0 | 0.6 | 0.6 | 0.0 | 0.0 | -0.4 | -0.4 | -4.5 | -184 | -76 | 14 | 11 | 42 | 6.2 | 13 | -17 | 26 | 0.9 | 26 | 33 | 28 | 22 | 21 | 11 | -105 | 6.5 | -66 | |
| – | – | – | – | – | – | – | 0.0 | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 105 | – | – | -179 | 0.8 | 0.8 | 0.5 | 0.2 | 0.2 | 0.5 | 0.0 | 0.3 | – | – | – | 0.5 | – | – | 0.3 | – | – | 0.0 | 0.0 | 0.0 | – | – | – | |
| – | – | – | – | -6.5 | -6.5 | -6.5 | -6.5 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | 0.0 | -0.1 | 9.3 | -0.1 | -0.1 | – | – | – | – | -0.4 | -0.1 | -0.3 | -0.2 | -0.2 | -0.7 | -1.6 | 11 | 8.6 | |
| – | 9.4 | 0.0 | 5.9 | 105 | -0.8 | 170 | 188 | 0.8 | 0.7 | 0.4 | 0.5 | 0.1 | 0.4 | -0.1 | 9.5 | -0.1 | 0.3 | -0.1 | 59 | 3.1 | 27 | 0.3 | 0.3 | 0.1 | -0.2 | -0.2 | 0.7 | 140 | 0.1 | 140 | |
| -4.0 | 4.8 | -3.2 | 3.1 | 96 | -6.9 | 161 | 175 | -4.4 | -20 | -25 | -21 | -205 | -93 | -17 | -0.2 | 14 | -25 | -18 | 2.8 | -8.4 | 1.5 | 0.6 | 1.5 | 3.0 | -1.3 | 4.1 | -7.1 | 16 | -9.4 | 3.6 | |
| -4.0 | -4.6 | -3.2 | -2.8 | -9.0 | -6.2 | -9.6 | -14 | -5.1 | -21 | -25 | -22 | -21 | -17 | -31 | -21 | -29 | -33 | -30 | -40 | -38 | -27 | -26 | -32 | -25 | -23 | -17 | -19 | -19 | -16 | -71 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.